The US Federal Trade Commission (FTC) has just issued an enforcement policy statement requiring marketers of homeopathic products to ‘effectively communicate the lack of scientific evidence’ on product labels.
The move is being heralded as the first time that homeopathic products will legally require a label stating that they don’t work.
Numerous submissions to the FTC report cited the Australian 2015 comprehensive assessment of evidence by the NHMRC, which concluded there is no reliable evidence that homeopathy is effective for any health conditions.
Although the evidence overwhelmingly supports the new FTC policy, much of their report deals with legal issues, possibly pre-empting industry arguments that regulating advertising claims might be inconsistent with the US First Amendment around free speech.
The FTC policy does not constitute a new law, but it clarifies the minimum standards for homeopathic health claims, which until now have largely been left to self-regulation. Homeopathic products will now “be held to the same truth-in-advertising standards as other products claiming health benefits.”
But not all is rosy… Continue reading